Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma

FASEB Journal

Volumn 17, Issue 6, 2003, Pages 598-609

  Hedborg, Fredrik ^a,b   Ullerås, Erik ^a,c   Grimelius, Lars ^a   Wassberg, Erik ^d   Maxwell, Patrick H ^e   Hero, Barbara ^f   Berthold, Frank ^f   Schilling, Freimut ^g   Harms, Dieter ^h   Sandstedt, Bengt ⁱ   Franklin, Gary ^c,j  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF COLOGNE   (Germany)

^g Biacore AB ^*  (Germany)

^h UNIVERSITY OF KIEL   (Germany)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j BIACORE AB   (Sweden)

more..

Author keywords

Angiogenesis; Differentiation; Insulin like growth factor; Sympathetic nervous system; Vascular endothelial growth factor

Indexed keywords

SOMATOMEDIN; VASCULOTROPIN; ANGIOGENIC FACTOR; NEUROMODULIN; SOMATOMEDIN B; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ADRENERGIC SYSTEM; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CELL CULTURE; CELL STRUCTURE; CELL TYPE; CHROMAFFIN CELL; CONTROLLED STUDY; EMBRYO; EVIDENCE BASED MEDICINE; FETUS; GANGLION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; METAPLASIA; MOLECULAR BIOLOGY; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; XENOGRAFT; ADULT; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; NEWBORN; PATHOLOGY;

ANIMALIA;

ADULT; ANGIOGENESIS INDUCING AGENTS; CELL HYPOXIA; CHROMAFFIN CELLS; FETUS; GAP-43 PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR II; METAPLASIA; NEUROBLASTOMA; NEURONS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0037387731     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0390com     Document Type: Article

References (48)

1. Olshan, A. F., and Bunin, G. R. (2000) Epidemiology of neuroblastoma. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voûte, P. A., eds) pp. 33-39, Elsevier, Amsterdam
2. Påhlman, S., and Hedborg, F. (2000) Development of the neural crest and sympathetic nervous system. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voute, P. A., eds) pp. 9-19, Elsevier, Amsterdam
3. Coupland, R. E. (1965) The Natured History of the Chromaffin Cell, Longmans Green, London
4. Barson, A. J. (1978) Congenital neoplasia; the society's experience. Arch. Dis. Child. 53, 436
5. Harms, D., Schmidt, D., and Leuschner, I. (1989) Abdominal, retroperitoneal, and sacrococcygeal tumors of the newborn and the very young infant. Eur. J. Pediatr. 148, 720-728
6. Berthold, F. (1990) Overview: biology of neuroblastoma. In Neuroblastoma: Tumor biology and Therapy (Pochedly, C., ed) pp. 1-27, CRC Press, Boca Raton
7. Mugishima, H., and Sakurai, M. (2000) Symptoms of neuroblastoma: paraneoplastic syndromes. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voûte, P. A., eds) pp. 293-301, Elsevier, Amsterdam
8. Ambros, P. F., and Brodeur, G. M. (2000) Concept of tumorigenesis and regression. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voûte, P. A., eds) pp. 21-32, Elsevier, Amsterdam
9. Hartmann, O., and Berthold, F. (2000) Treatment of advanced neuroblastoma: the European experience. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voûte, P. A., eds) pp. 437-452, Elsevier, Amsterdam
10. Matthay, K. K., and Castleberry, R. P. (2000) Treatment of advanced neuroblastoma: the US experience. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voûte, P. A., eds) pp. 417-436, Elsevier, Amsterdam
11. Tsuchida, Y., and Kaneko, M. (2000) Treatment of advanced neuroblastoma: the Japanese experience. In Neuroblastoma (Brodeur, G. M., Sawada, T., Tsushida, Y., and Voûte, P. A., eds) pp. 453-469, Elsevier, Amsterdam
12. Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J., Joshi, V. V., and Roald, B. (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86, 349-363
13. Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J., Joshi, V. V., Roald, B., Stram, D. O., Gerbing, R. B., Lukens, J. N., Matthay, K. K., et al. (1999) The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86, 364-372
14. Hedborg, F., Bjefman, C., Sparén, P., Sandstedt, B., and Påhlman, S. (1995) Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favorable outcome. Eur. J. Cancer 4, 435-443
15. Cooper, M. J., Hutchins, G. M., Cohen, P. S., Helman, L. J., Mennie, R. J., and Israel, M. A. (1990) Human neuroblastoma cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ. 1, 149-159
16. Gestblom, C., Hoehner, J. C., Hedborg, F., Sandstedt, B., and Påhlman, S. (1997) In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastoma. Am. J. Pathol. 150, 107-117
17. Hedborg, F., Ohlsson, R., Sandstedt, B., Grimelius, L., Hoehner, J. C., and Påhlman, S. (1995) IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am. J. Pathol. 146, 833-847
18. Hoehner, J., Hedborg, F., Eriksson, L., Sandstedt, B., Grimelius, L., Olsen, L., and Pahlman, S. (1998) Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab. Invest. 78, 29-45
19. Hoehner, J. C., Gestblom, C., Hedborg, F., Sandstedt, B., Olsen, L., and Påhlman, S. (1996) A developmental model of neuroblastoma: differentiating stroma-poor tumors progress along an extra-adrenal chromaffin lineage. Lab. Invest. 75, 659-675
20. Evans, A. E., D'Angio, G. J., and Randolph, J. (1971) A proposed staging system for children with neuroblastoma. Cancer 27, 374-378
21. Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V., Castleberry, R. P., DeBernardi, B., Evans, A. E., Favrot, M., Hedborg, F., et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 11, 1466-1477
22. Hodgkiss, R. J., Jones, G., Long, A., Parrick, J., Smith, K. A., Stratford, M. R., and Wilson, G. D. (1991) Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br. J. Cancer 63, 119-125
23. Hodgkiss, R. J., Webster, L., and Wilson, G. D. (1997) Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP). Adv. Exp. Med. Biol. 428, 61-67
24. Grimelius, L., and Wilander, E. (1980) Silver stains in the study of endocrine cells of the gut and pancreas. Invest. Cell Pathol. 3, 3-12
25. Ohlsson, R., Holmgren, L., Glaser, A., Szpecht, A., and Pfeifer-Ohlsson, S. (1989) Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth. EMBO J. 8, 1993-1999
26. Shen, Y., Mani, S., Donovan, S. L., Schwob, J. E., and Meiri, K. F. (2002) Growth-associated protein-43 is required for commissural axon guidance in the developing vertebrate nervous system. J. Neurosci. 22, 239-247
27. El-Badry, O. M., Romanus, J. A., Helman, L. J., Cooper, M. J., Rechler, M. M., and Israel, M. A. (1989) Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Invest. 84, 829-839
28. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12, 149-162
29. Brown, J. M. (1999) The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res. 59, 5863-5870
30. Siemann, D. W. (1998) The tumor microenvironment: a double-edged sword. Int. J. Radiat. Oncol. Biol. Phys. 42, 697-699
31. Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W. (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943
32. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509-4515
33. Carmeliet, P., and Rakesh, K. J. (2000) Angiogenesis in cancer and other diseases. Nature (London) 407, 249-257
34. Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., and Livingston, D. M. (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6, 1335-1340
35. Semenza, G. L. (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35, 71-103
36. Rijken, P. F., Bernsen, H. J., Peters, J. P., Hodgkiss, R. J., Raleigh, J. A., and van der Kogel, A. J. (2000) Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys. 48, 571-582
37. Slack, J. M. W., and Tosh, D. (2001) Transdifferentiation and metaplasia-switching cell types. Curr. Opin. Genet. Dev. 11, 581-586
38. Langley, K., and Grant, N. J. (1999) Molecular markers of sympathoadrenal cells. Cell Tissue Res. 298, 185-206
39. Kim, K. W., Bae, S. K., Lee, O. H., Bae, M. H., Lee, M. J., and Park, B. C. (1998) Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res. 58, 348-351
40. Bae, S. K., Bae, M. H., Ahn, M. Y., Son, M. J., Lee, Y. M., Bae, M. K., Lee, O. H., Park, B. C., and Kim, K. W. (1999) Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 59, 5989-5994
41. Feldser, D., Agani, F., Iyer, N. V., Pak, B., Ferreira, G., and Semenza, G. L. (1999) Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59, 3915-3918
42. Jackson, A., and Nurse, C. (1995) Plasticity in cultured carotid body chemoreceptors: environmental modulation of GAP-43 and neurofilament. J. Neurobiol. 26, 485-496
43. Semenza, G. L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578
44. Yan, S. F., Lu, J., Zou, Y. S., Soh-Won, J., Cohen, D. M. Buttrick, P. M., Cooper, D. R., Steinberg, S. F., Mackman, N., Pinsky, D. J., et al. (1999) Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 274, 15030-15040
45. Kietzmann, T., and Jungermann, K. (1997) Modulation by oxygen of zonal gene expression in liver studied in primary rat hepatocyte cultures. Cell Biol. Toxicol. 13, 243-255
46. Soulier, V., Gestreau, C., Borghini, N., Dalmaz, Y., Cottet-Emard, J. M., and Pequignot, J. M. (1997) Peripheral chemosensitivity and central integration: neuroplasticity of catecholaminergic cells under hypoxia. Comp. Biochem. Physiol. A Physiol. 118, 1-7
47. Morrison, S. J., Csete, M., Groves, A. K., Melega, W., Wold, B., and Anderson, D. J. (2000) Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J. Neurosci. 20, 7370-7376
48. Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., and McKnight, S. L. (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12, 3320-3324